To realise the potential of medical device data and maintain security protocols in a more connected medtech reality, network architecture must evolve.

Baxter’s share price declined by almost 23% on 31 July following the disclosure of disappointing Q2 2025 results that prompted the company to trim its 2025 profit outlook.

Trividia Health UK has launched the TRUEplus 5-Bevel Pen Needles in the country, marking the product's first entry outside the US.

Becton, Dickinson and Company (BD) has announced its submission of an application to the FDA for an at-home human papillomavirus (HPV) test.

Founder Juan José Chacón-Quiros discusses how Establishment Labs is transforming breast reconstruction and aesthetics with innovative, patient-focused solutions.

Natera has announced the initiation of the Phase II TEODOR trial of its Signatera test aimed at certain breast cancer patients.

AI in the healthcare space has outpaced the rate of regulation, and without an update, HIPAA risks stifling innovation. The use of artificial intelligence (AI) and generative AI (GenAI) in the ...

Following a period of relative dormancy, research and development in the Alzheimer’s disease space is booming. And mounting attention, both in the development of disease modifying therapies (DMTs) and ...

Maui Imaging has secured $14m in a Series D financing round, including equity funding, for supporting CET-based imaging technology.

Axonius has acquired New York-headquartered healthcare cybersecurity firm Cynerio in a $100m cash and stock deal.

The FDA has approved SetPoint Medical’s neuroimmune modulation device, SetPoint System, to treat moderate-to-severe rheumatoid arthritis.

Johnson & Johnson MedTech has launched the VIRTUGUIDE System, an AI-powered Lapidus solution to minimise bunion surgery complexities.